Cambridge Investment Research Advisors’s CapForce IBD Breakout Opportunities ETF BOUT Stock Holding History

Cambridge Investment Research Advisors’s Portfolio BOUT Stock Details BOUT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5,296	Closed	-$205K	–	3173
2021 Q4	$205K	Sell	5,296 -3,150	-37%	-$116K	﹤0.01%	2875
2021 Q3	$289K	Buy	8,446 +250	+3%	+$8.64K	﹤0.01%	2496
2021 Q2	$273K	Sell	8,196 -200	-2%	-$6.69K	﹤0.01%	2542
2021 Q1	$278K	Buy	+8,396	New	+$288K	﹤0.01%	2335

Other funds holding BOUT

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

WAP

Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return

CAG

Csenge Advisory Group Clearwater, Florida $2.18B AUM 16.73% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

PFGIA

Patriot Financial Group Insurance Agency Westborough, Massachusetts $974M AUM 29.77% 1-Year Est. Return

APA

American Portfolios Advisors Holbrook, New York $2.36B AUM 14.59% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

ADL

Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Cambridge Investment Research Advisors's BOUT Position: Q1 2022 in Review

Cambridge Investment Research Advisors sold out of CapForce IBD Breakout Opportunities ETF (BOUT) in Q1 2022, closing a stake of 5,296 shares — an estimated $205K sold.

Cambridge Investment Research Advisors first reported a position in BOUT in Q1 2021 and held it in 4 quarters. The position peaked at $289K in Q3 2021. 14 funds tracked by Wall St. Rank hold BOUT as of Q1 2022.

Cambridge Investment Research Advisors reported no remaining CapForce IBD Breakout Opportunities ETF position as of Q1 2022 after selling out during the quarter.
Cambridge Investment Research Advisors sold 5,296 CapForce IBD Breakout Opportunities ETF shares in Q1 2022, an estimated $205K.
Cambridge Investment Research Advisors first reported a position in CapForce IBD Breakout Opportunities ETF in Q1 2021 and held it in 4 quarters.
Cambridge Investment Research Advisors's CapForce IBD Breakout Opportunities ETF position peaked at $289K in Q3 2021.
14 funds tracked by Wall St. Rank held CapForce IBD Breakout Opportunities ETF as of Q1 2022.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2022, filed 12 May 2022.